Metraipolis › archive › dc_8fb4603723f3

Emerging Nanocarrier Strategies for Optimized Drug Delivery in the Treatment of Primary Bone Cancer — Europe PMC PMID:42358836

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358836
DOI
10.32604/or.2026.077723
License (as archived)
solo-consultazione
Archived
2026-10-19T09:27:52.868Z
SHA-256 of the archived text
c7335a43df533b16774223d558ffd9a94a77f696ea95b0db7bea688363d1342a
Stable URL of this page
https://metraipolis.com/documento/dc_8fb4603723f3

How to cite

Emerging Nanocarrier Strategies for Optimized Drug Delivery in the Treatment of Primary Bone Cancer — Europe PMC PMID:42358836 — Europe PMC (en), https://europepmc.org/article/MED/42358836 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8fb4603723f3 (Metraipolis archive dc_8fb4603723f3, sha256 c7335a43df533b16774223d558ffd9a94a77f696ea95b0db7bea688363d1342a)
BibTeX
@misc{dc8fb4603723f3,
  title = {Emerging Nanocarrier Strategies for Optimized Drug Delivery in the Treatment of Primary Bone Cancer — Europe PMC PMID:42358836},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358836},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8fb4603723f3; sha256 c7335a43df533b16774223d558ffd9a94a77f696ea95b0db7bea688363d1342a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358836. Agents can read the archived copy with the MCP tool read_document.